纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
- 种属
- Human
- 表达系统
- HEK293
蛋白结构
加载中…
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
纯度 > 95% as determined by Bis-Tris PAGE 内毒素 Less than 1 EU per μg by the LAL method. 100 μg
蛋白结构
| 分子名 | 目录号 | 种属 | 表达宿主 | 产品描述 | 蛋白结构 |
|---|---|---|---|---|---|
| HLA-A*24:02 | HLAA2402-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*24:02 (25–305) AviHis |
| HBV | HBV-HP002 | Human | HEK293 | Human HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | HBV (25–305) AviHis |
| HLA-A*11:01 | HLAA1101-HP005 | Human | HEK293 | Human Peptide Ready HLA-A*11:01&B2M Monomer Protein, Ultra Low Endotoxin 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*11:01 (25–305) AviHis |
| Survivin 2B | SURVIVIN2B-HP003 | Human | HEK293 | Human HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) Tetramer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | Survivin 2B (25–305) AviHis |
| MAGE-A4 | MAGEA4-HB003 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A4 (25–305) AviHis |
| MAGE-A4 | MAGEA4-HP004 | Human | HEK293 | Human HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) Tetramer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A4 (25–305) AviHis |
| NY-ESO-1 | NYESO1-HP009 | Human | HEK293 | Human NY-ESO-1 TCR&CD3 Complex VLP 纯度 > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | NY-ESO-1 |
| HLA-A*33:03 | HLAA3303-HB002 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*33:03&B2M Monomer Protein, Ultra Low Endotoxin 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*33:03 (25–305) AviHis |
| HLA-E*01:03 | HLAE0103-HB003 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-E*01:03&B2M Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | HLA-E*01:03 (22–302) AviHis |
| HLA-A*02:01 | HLAA0201-HB015 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*02:01&B2M Monomer Protein, Ultra Low Endotoxin 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*02:01 (25–305) AviHis |
| HBV | HBV-HP003 | Human | HEK293 | Human HLA-A*02:01&B2M&HBV (FLLTRILTI) Tetramer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | HBV (25–305) AviHis |
| HLA-A*24:02 | HLAA2402-HB002 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer Protein, Ultra Low Endotoxin 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*24:02 (25–305) AviHis |
| MAGE-A3 | MAGEA3-HB004 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MAGE-A3 (KVAELVHFL) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A3 (25–305) AviHis |
| HLA-A*02:01 | HLAA0201-HB014 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*02:01&B2M Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*02:01 (25–305) AviHis |
| CMV pp65 | CMVPP65-HB003 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&CMV pp65 (NLVPMVATV) Monomer Protein, Ultra Low Endotoxin 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 0.01 EU per μg by the LAL method. 100 μg | CMV pp65 (25–305) AviHis |
| KRAS WT | KRASWT-HB003 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | KRAS WT (25–305) AviHis |
| HLA-B*27:05 | HLAB2705-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-B*27:05&B2M Monomer Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | HLA-B*27:05 (25–305) AviHis |
| LILRA5 | LILRA5-HB001 | Human | HEK293 | Biotinylated Human LILRA5/CD85f/ILT11 Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | LILRA5 (42–268) AviHis |
| LILRB3 | LILRB3-HB001 | Human | HEK293 | Biotinylated Human LILRB3/CD85a/ILT5 Protein 纯度 > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | LILRB3 (24–443) AviHis |
| CD74 | CD74-HB001 | Human | HEK293 | Biotinylated Human CD74/DHLAG Protein (Primary Amine Labeling) 纯度 > 95% as determined by Bis-Tris PAGE 内毒素 Less than 1 EU per μg by the LAL method. 100 μg | CD74 (73–232) His |